iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Unusually-High Trading Volume – What’s Next?

Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw strong trading volume on Thursday . 218,321 shares changed hands during trading, an increase of 270% from the previous session’s volume of 58,936 shares.The stock last traded at $67.62 and had previously closed at $67.54.

iShares U.S. Pharmaceuticals ETF Stock Performance

The business’s fifty day moving average price is $69.30 and its two-hundred day moving average price is $69.01. The stock has a market capitalization of $675.89 million, a P/E ratio of 6.49 and a beta of 0.58.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Aptus Capital Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at about $12,165,000. Rockport Wealth LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the second quarter valued at approximately $12,091,000. Flow Traders U.S. LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the third quarter valued at approximately $839,000. Kraft Davis & Associates LLC raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 30.6% during the 2nd quarter. Kraft Davis & Associates LLC now owns 31,722 shares of the company’s stock worth $2,197,000 after buying an additional 7,428 shares during the period. Finally, Marshall Wace LLP purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at approximately $422,000.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.